Benin Management Corp »

Ovid Therapeutics shares owned by Benin Management Corp

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Benin Management Corp from 13F filings

Historical chart of Benin Management Corp investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Benin Management Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Benin Management Corp

Quarter filed Position value Share count Share price at filing
2025-12-31 $31k 19k 1.63

More positions owned by Benin Management Corp

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Visa Com Cl A (V)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Alphabet Cap Stk Cl C (GOOG)
Pepsi (PEP)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Allstate Corporation (ALL)
PNC Financial Services (PNC)
Exxon Mobil Corporation (XOM)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Benin Management Corp

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Affinity Asset Advisors
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Point72 Asset Management
Vanguard Group
Saturn V Capital Management
Ally Bridge Group
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Marshall Wace
Acadian Asset Management

View all funds holding Ovid Therapeutics